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Abstract: With the increasing incidence and mortality of obesity, obesity-related health problems have become a world-
wide priority. Clinical observation shows that obesity related to adipocyte differentiation is an important pathogenic fac-
tor of insulin resistance, and weight loss can reduce insulin resistance, indicating that obesity is related to insulin resis-
tance. As the understanding of mechanism between obesity, cytokines, hormones and insulin resistance becomes clear, it 
is possible that these cytokines or hormones could be used in the use of biomarkers and the design of targeted therapies 
for insulin resistance. This review provides an overview of how obesity effect adipokines，hepatokines and inflamma-
tory cytokines whose changes result in or exacerbate insulin resistance.
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1.	INTRODUCTION
Obese patients are often accompanied by insulin resistance (IR). Insulin resistance (IR) is the reduction or 
disappearance of the response of target organs and tissues of insulin action, such as liver, muscle and adipose tissue, to 
the biological effect of insulin, resulting in a series of pathophysiological changes and clinical manifestations.
Adipokines are a class of cytokines or hormones secreted by white fat cells. It has shown that the occurrence of 
obesity is mainly due to abnormal secretion of adipocytes, large increase of adipocytes and excessive deposition of lipids 
in cells. Hepatokines are liver-derived proteins. The first hepatokine that has been proven to have a major pathogenetic 
role in metabolic diseases is α2-HS-glycoprotein (fetuin-A).Inflammatory cytokines are various cytokines involved in 
the inflammatory response. Mainly has the tumor necrosis factor-α (TNFα), interleukin-1β (IL-1β), interleukin 6 (IL - 
6), transforming growth factor β (TGF - β), etc. 
There is clear evidence that adipokines, hepatokines, inflammatory cytokines play an important role in the 
development of abnormal glucose and lipid metabolism, especially about the cause of insulin resistance. In this article I 
discuss some of the cytokines or hormonal changes caused by obesity that cause or exacerbate insulin resistance.
2.ADIPOKINES
Adipokines are produced by white or brown fat tissue. As a result patients that are obese or overweight will change 
the body fat rate or the ratio of white to brown fat which will change the level of adipokines content in serum. 
2.1	Leptin
Leptin and its receptors play an important role in the process of glucose metabolism. Leptin can enhance the 
sensitivity of surrounding tissues to insulin and the uptake of glucose. As a negative regulator of insulin, leptin may 
be partly involved in insulin resistance. The insulin reactivity and inhibition of glycogen synthesis were reduced in 
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hepatoma cells and isolated fat cells exposed to high concentrations of leptin. Lu Hongyun et al. found that the variation 
frequency of THE leptin receptor gene at exon 203057 G-A was significantly different between T2DM and normal 
glucose tolerance group. It is the abnormal expression of leptin that damages the feedback regulation system of the 
hypothalamic-pituitary-adrenal axis in OB/OB mice, thus causing insulin resistance. Studies have shown that serum 
leptin levels are associated with body mass index, and levels of the adipocytokine gene rise when body fat levels are 
high. 
2.2 Resistin
Resistin is a kind of peptide hormone secreted by fat cells in the body. As it is related to insulin resistance, it was 
named resistin. Studies have found that resistin has a significant pro-inflammatory effect. Resistin is closely related to 
inflammatory responses, and many inflammatory responses are accompanied by the elevation of resistin. It was found 
that the expression level of inflammatory factors in monocytes of human peripheral blood was significantly increased 
by stimulating human peripheral blood monocytes with high concentration of resistin. Steppan found that resistin does 
not directly reduce phosphorylation of IRS-1 serine residues, but indirectly by reducing phosphorylation of IR tyrosine 
residues. Resistin induces insulin signaling abnormalities by stimulating inflammatory signaling pathways. Both theory 
and experiment suggest that obese people have higher levels of resistin. 
2.3	Adiponectin
Adiponectin (ADI) was first discovered to be an endocrine active serum protein secreted by adipose tissue. 
ADI in human body is not only mainly produced by white fat, but also can be produced in small amounts in liver, 
myocardium, fetal disk and other tissues. [1] Adiponectin can stimulate the body to release anti-inflammatory cytokines, 
inhibit the production of pre-inflammatory factors, and play an anti-inflammatory role. But, when the body remains in 
the prolonged state of insulin resistance, inflammation would expand gradually, forming of chronic inflammation. [2]
However, after obesity is reached, the ability of adipose tissue to secrete ADI decreases, and the body becomes less 
sensitive to insulin, resulting in IR。[3] Kralisch et al. used the mouse model of adiponectin gene elimination, and found 
that mice showed severe insulin resistance. And they also indicates that adiponectin is involved in the occurrence and 
development of insulin resistance. 
2.4	Zinc-α2-glycoproteins，ZAG
ZAG, a soluble protein with a molecular weight of about 43kDa, is a member of the major histocompatibility 
complex Type I family. Studies suggest that the increase of circulating ZAG level can increase insulin sensitivity and 
reduce the body’s insulin resistance through the glucose metabolism signaling pathway. The new study found that ZAG 
interacts with adipokines，such as adiponectin (ADI), in different tissues to regulate the body's insulin sensitivity. A 
study on metabolic syndrome suggested that serum ZAG level and ADI level of newly developed metabolic syndrome 
patients were lower than those of healthy control group, both of which were significantly negatively correlated with 
BMI. Studies on subcutaneous fat ZAG reported that the level of subcutaneous fat ZAG in people with normal body 
mass index was about 3.3 times higher than that in visceral fat tissue. However, the difference disappeared among the 
extremely obese.[1] 
In summary, adipose tissue in obese people changes the amount of these adipokines they secrete. Then some 
adipokines would cause inflammation at last which contribute to the insulin resistance. And others can reduce insulin 
resistance by making cells more sensitive to insulin. After all their working mechanism are similar in general.
3	HEPATOKINES
Obesity has a huge impact on the liver, changing the amount of hepatokines.
3.1		Fibroblast	Growth	Factor,FGF-21
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FGF21, a member of the FGF superfamily, is a secreted protein expressed mainly in the liver[4]，It is mainly 
regulated by the peroxisome proliferator-activated receptor and the insulin/protein kinase 1 pathway. It can be expressed 
in liver, fat, pancreas and muscle tissues, and plays an important role in improving insulin sensitivity and glucose and 
lipid metabolism. Xu Tongyu et al. speculate FGF21 improving insulin resistance in type 2 diabetic model mice may 
be by reducing inflammatory factors. The study of Zhang Nan et al. showed that the serum FGF21 level of obese or 
overweight patients was significantly increased, which was related to BMI, IR and other factors. The mechanism may be 
related to “FGF21 resistance” caused by compensatory increase of serum FGF21 level in pathological conditions such 
as obesity or overweight, hyperglycemia, etc. 
3.2	Hepassocin
Hepassocin is a liver-specific growth factor that has been found to participate in the regulation of proliferation 
of hepatocytes and regeneration of the liver. The study of Wu Hung-Tsung et al. which based on HepG2 liver cancer 
cells showed that Hepassocin could block insulin signaling pathway and induce insulin resistance through an ERK1/2 
dependent signaling pathway. The study of Ru-Lai Huang et al. provides evidence that subjects who are overweight 
or obese had significantly higher hepassocin concentrations than those of subjects who had a normal weight. Taken 
together, it suggest that hepassocin might be a link between obesity, and IR, and could be a potential candidate in 
developing comprehensive diagnostic/therapeutic approaches to manage these diseases. 
3.3 Fetuin A
Fetuin-A is an endogenous natural insulin receptor tyrosine kinase inhibitor. It can directly inhibit the 
phosphorylation of insulin receptors, alter the downstream signaling molecules AMPK (AMP kinase) and AKT, 
and cause signal transduction disorder, causing IR.[5] Free fatty acids are known to stimulate the secretion of pro-
inflammatory cytokines by adipocytes through toll-like receptor 4 (TLR4), leading to IR. Pal and Dasgupta et al. have 
shown Fetuin-A ACTS as an adaptor protein between free fatty acids and TLR4, and these findings suggest that Fetuin-a 
can enhance IR by this pathway.[6] To establish the link with obesity, the study showed that fetuin-A concentration in the 
T2DM group was higher than that in the control group. 
3.4 Fetuin B
Fetuin B is the second member of the fetuin family, an endogenous inhibitor of the insulin receptor tyrosine kinase, 
and is produced primarily in liver tissue. In hepatocytes, fetuin B inhibits glucose metabolism pathways by inhibiting 
genes encoding 6 phosphoglucose and phosphoenolpyruvate carboxykinase, thereby reducing insulin sensitivity. [7] 
However, further studies are needed to elucidate the differences between in vitro and in vivo results and the specific 
molecular mechanisms by which fetuin B affects glucose metabolism. In humans, plasma fetuin B levels are increased 
in obese individuals with hepatic steatosis and T2D, and associated positively with intrahepatic triglyceride and insulin 
resistance.[8] Besides, Serum fetuin B levels were significantly higher in obese adults in relation to the metabolic 
syndrome than in the control group. 
In conclusion, Liver factors can affect insulin resistance by affecting insulin-related pathways or changing other 
inflammatory cytokines, making the IR better or worse.
4	INFLAMMATORY	CYTOKINES
Obesity is now widely recognized as a chronic inflammation which means that inflammatory cytokines and BMI 
have a strong relationship.
4.1	Secreted	Frizzled	Related	Protein5,SFRP5
Secreted frizzled related protein 5 (SFRP5), which is one of the members of the SFRP protein family, can be 
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secreted by adipose tissue and is considered to be a bioactive substance closely related to autoinflammatory. Long-term 
chronic autoinflammation in the body is closely related to the occurrence of insulin resistance. Currently, it is believed 
that it can reduce the level of autoinflammation by antagonizing WNT/β -catenin pathway, and play a role in improving 
insulin resistance. Studies have found that the lung tissue expression of SFRP5 of the insulin resistance mice is less than 
that of mice without insulin resistance. Liu et al. believed that Sfrp5 may play an induction role in the proliferation, 
differentiation and maturation of adipogenic precursor cells, thereby reducing lipid deposition. And SFRP5 was 
negatively correlated with BMI. 
4.2	TNF-α
TNF-α is the first inflammatory factor to link inflammation with insulin function. Studies have shown that 
increased production of fat-derived TNF-α has an important impact on insulin resistance in obese people. TNF-α can 
affect insulin function directly or indirectly through a variety of pathways. Direct pathways include induction of IRS-
1 serine phosphorylation, down-regulation of IRS-1 expression, and reduction of GLUT-4. TNF-α can also indirectly 
induce insulin resistance in a number of ways. One of the most important is to increase FFA levels in the blood by 
stimulating MAPK mediated lipolysis of fat cells, which is activated by multiple pathways. Gasic et al. found that 
TNF-α induced G protein reduction is the most important mechanism causing lipolysis in rodents. In humans, increased 
levels of perilipin phosphorylation and decreased expression are the main factors causing the lipolysis effect of TNF-α. 
In addition, TNF-α can induce insulin resistance by inducing chronic inflammation in adipose tissue.[9] And Levels of 
TNF- were higher in both normal and T2DM patients than in non-obese patients. 
4.3	IL-6
Adipose tissue is the main secreted tissue of IL-6, and the concentration of IL-6 in blood is positively correlated 
with obesity, impaired glucose tolerance and insulin resistance. IL-6 has a direct effect on insulin conduction in 
adipocytes and hepatocytes. In fat cells, IL-6 reduces protein expression of insulin receptor subunits and IRS-1, lowers 
insulin-mediated tyrosine kinase phosphorylation levels and insulin receptor subunit activity, and inhibits insulin-
mediated glucose transport and fat formation by down-regulating glut-4 expression. In the adipose tissue of insulin 
resistant people, IL-6 mRNA expression increases, leading to a decrease in the insulin-mediated glucose treatment ratio. 
Studies have shown that IL-6 enhances glucose transport by enhancing the intrinsic activity of Glut-1 after treatment of 
3T3-L1 fat cells. And BMI is an independent influence factor for il-6 elevation. 
4.4 MCP-1
MCP-1 is a member of the monocyte chemotactic protein family. MCP-1 promotes the migration of inflammatory 
cells through chemotaxis in upregulated inflammatory molecules in adipose tissue of obese animals and humans. 
JIMENEZ - SAINZ et al. study found that activated by MCP - 1 extracellular signal regulating kinase (ERK) can cause 
a variety of downstream signal transduction events. MCP - 1 separately passivation of muscle cells and skeletal muscle 
insulin signaling and insulin stimulates glucose uptake, the two ways of alternating [10] may lead to insulin resistance. 
Tang et al. found that the McP-1 level of simple obesity patients was 25% higher than that of the normal control group, 
and the difference was statistically significant. 
Inflammatory cytokines often act directly on insulin signaling pathways or glucose signaling pathways, causing 




The conclusion for the content of hormones and cytokines in obese people which increased insulin 
resistance(↑stands for higher concentration levels in serum ,↓stands for lower concentration levels in serum than that in 
normal weight)
Obesity can change the secretion of cytokines, thus affecting metabolism and immune regulation pathways, leading 
to or promoting metabolic disorders. These cytokines are part of a complex network that mediates communication 
between fat, liver, muscle and immune system. Disorders in the content of certain hormones and cytokines can lead to 
metabolic disorders. At present, these hormones and cytokines have not been all used directly in the clinical treatment 
of insulin resistance. To my knowledge, leptin is used as a drug which is the treatment of congenital leptin deficiency 
obesity only, not used to treat IR. 
However, given the disease-related changes in levels of relevant cytokines, the factors may serve as biomarkers for 
the early detection of insulin resistance, for instance, the rise of leptin, reisitin, adiponectin, FGF21. Moreover, based 
on preclinical studies, certain cytokines (FGF21, leptin, adiponectin, ZAG, MCP-1) can improve insulin sensitivity and 
may emerge as novel targets for broader and more efficient treatments as well as for prevention of insulin resistance. For 
example, thiazolidinediones is currently used to reduce insulin sensitivity, it works by increasing circulating adiponectin 
levels.Celastrol can increase insulin sensitivity by increasing leptin levels (which has not been used clinically)
Some cytokine especially the inflammatory cytokines and hepatokines or others like reisitin that cause insulin 
signaling abnormalities due to their elevated levels can be a target. The decomposing enzymes or inhibiting enzymes 
of them should also be considered as targets for treatment of endocrine disorders caused by obesity (not only insulin 
resistance, but also other diseases, such as atherosclerosis). 
It is also worth investigating whether the use of external factors to force the increase of certain hormones and 
cytokines (such as ZAG, SFRP5) can reduce insulin resistance. After all, there is only evidence that BMI and IR affect 
the levels of some cytokines, and there is no evidence that increasing their levels reduces insulin resistance. Last but not 
least, methods of targetting specific insulin receptors is also a question worth thinking about in drug development.
The exact cause of insulin resistance has not yet been determined, but once it is, the mechanism by which these 
hormones and cytokines act will become clearer. And in the future drug research will also be more clearly targeted.
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